Anzeige
01.10.2022 | Case report
Ocrelizumab/tozinameran interaction
Myalgia, fatigue and negative anti-SARS-CoV-2 S antibody response: case report
Erschienen in: Reactions Weekly | Ausgabe 1/2022
Einloggen, um Zugang zu erhaltenExcerpt
Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event
-
* Drug interaction